|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
1U54CA190163-01
|
$678,281
|
$13,566
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-04
|
$862,508
|
$293,253
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$750
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$1,485
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$35,852
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell Carcinoma
|
5F31CA168337-03
|
$42,676
|
$42,676
|
JIMENEZ, LIZANDRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
5R01CA170911-03
|
$336,129
|
$168,065
|
LIBUTTI, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$94,615
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Development of breakthrough intra-operative detector and imaging system for parat
|
9R42CA192243-02A1
|
$591,600
|
$195,228
|
MAHADEVAN-JANSEN, ANITA
|
ANASYS INSTRUMENTS CORPORATION
|
|
Targeted nanoparticles to deliver a multimodal peptide to head and neck tumors
|
1U43CA179506-01
|
$258,009
|
$258,009
|
PANDEY, NIRANJAN
|
ASCLEPIX THERAPEUTICS, LLC
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$449,836
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$976
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$2,996
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$54,934
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$3,306
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
|
5K08CA140780-05
|
$179,910
|
$89,956
|
GEWURZ, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-02
|
$647,864
|
$213,795
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterization of Oncogenic Transcription Factor-Associated Proteins in SCC
|
4R00CA157730-04
|
$241,532
|
$241,532
|
RAMSEY, MATTHEW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-19
|
$435,089
|
$348,072
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Deimmunized TLR5 Agonist for Anticancer Therapy
|
1R43CA176966-01A1
|
$223,303
|
$223,303
|
METT, VADIM
|
BUFFALO BIOLABS, LLC
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
1U10CA180853-01
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Histologic image-based aggressiveness prediction in p16+ oropharyngeal carcinoma
|
1R21CA179327-01A1
|
$185,934
|
$185,934
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role and Regulaton of the Human DEK Proto-Oncogene
|
5R01CA116316-08
|
$258,705
|
$258,705
|
WELLS, SUSANNE
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
|
5R01CA139633-05
|
$559,582
|
$139,896
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
|
5R01CA166559-03
|
$566,611
|
$283,306
|
LANDIER, WENDY
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$3,657
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$1,923
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$3,787
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$378
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$63,572
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Novel Agent That Reduces Radiation Side Effects in Head and Neck Cancer Patient
|
N43CA130014-004
|
$1,499,978
|
$1,499,978
|
ZARLING, DAVID
|
COLBY PHARMACEUTICAL COMPANY
|
|
Center on the Microenvironment and Metastasis
|
3U54CA143876-05S2
|
$161,591
|
$8,080
|
SHULER, MICHAEL
|
CORNELL UNIVERSITY
|
|
Center on the Microenvironment and Metastasis
|
3U54CA143876-05S3
|
$80,925
|
$4,046
|
SHULER, MICHAEL
|
CORNELL UNIVERSITY
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
1U10CA180867-01
|
$1,302,200
|
$32,555
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
1U10CA180854-01
|
$375,850
|
$18,793
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-40S1
|
$74,978
|
$750
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-40
|
$5,552,106
|
$55,521
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
HIF genes in head and neck cancer radiotherapy
|
5R01CA131408-06
|
$288,130
|
$288,130
|
LI, CHUAN-YUAN
|
DUKE UNIVERSITY
|
|
ECOG-ACRIN Operations Center
|
1U10CA180820-01
|
$13,778,655
|
$344,466
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-01S1
|
$130,000
|
$3,250
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-01S2
|
$81,845
|
$2,046
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
ECOG-ACRIN Operations Center
|
3U10CA180820-01S3
|
$259,771
|
$6,494
|
COMIS, ROBERT
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
p90RSK2-Stathmin Signaling in Metastatic Human Cancers
|
1F31CA183365-01
|
$42,676
|
$42,676
|
ALESI, GINA
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$2,994
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$62,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
|
1R01CA175316-01A1
|
$323,700
|
$106,821
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
1U10CA180864-01
|
$542,950
|
$54,295
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
A Novel genomics-based approach to differentiate HPV-positive and -negative HNC
|
1R21CA182661-01A1
|
$203,580
|
$203,580
|
SABA, NABIL
|
EMORY UNIVERSITY
|
|
Toxicity and Efficacy of Gold Nanoparticle Photothermal Therapy in Cancer
|
5U01CA151802-05
|
$377,136
|
$377,136
|
SHIN, DONG
|
EMORY UNIVERSITY
|
Total relevant funding to Head and Neck for this search: $57,146,502
|